Y90 Dosimetry Pre-Conference Training for Interventional Oncology in Miami Beach

Precision dosimetry is the lever that turns Y90 radioembolization into truly patient-specific therapy.

At the 2025 Symposium on Clinical Interventional Oncology (CIO), the educational program includes the highly anticipated Y90 Dosimetry Pre-Conference, an immersive workshop to deepen clinicians’ expertise in Y90 radioembolization dosimetry. The course combines practical knowledge with hands-on training.

CIO will be held October 17–19, 2025 at the Loews Miami Beach Hotel in Miami Beach, Florida. Our complimentary Y90 Dosimetry Pre-Conference Course, sponsored by an education grant from Sirtex, is Thursday, October 16. It is designed for interventional oncologists, interventional radiologists, nuclear medicine physicians, and radiation oncologists who want reliable, repeatable planning and verification in daily practice.

I have seen firsthand how precise dosimetry changes the trajectory of patient care. Understanding differences between glass and resin microspheres, balancing absorbed dose against safety, and planning treatment that truly spares healthy tissue are decisions that require skill, confidence, and practice. This pre-conference is designed to help you refine that skill set through simulated treatment planning across different therapeutic scenarios.

The Pre-CIO Y90 Dosimetry course is designed to not only give physicians technical training, but the confidence to deliver safer, more effective, and personalized treatments. By mastering concepts like advanced dosimetry models and post-treatment verification, participants will walk away with practical skills that directly translate into better patient care.

The Y90 Dosimetry Pre-Conference covers the essential areas every interventional oncologist, interventional radiologist, nuclear medicine physician, or radiation oncologist must master:

• Clinical and technical decision-making: Explore radiation segmentectomy and lobectomy, and walk through cases involving portal vein invasion or multifocal disease.
• Treatment planning and outcomes: Learn how to use the dosimetry software such as MIM Y90 platform and Cancer Y90 app to model dose distribution and streamline workflows.
• Dosimetry strategies: Gain confidence applying BSA, MIRD, and voxel-based methods, interpreting 99mTc-MAA SPECT/CT, and verifying treatments with Y-90 PET/CT.
• Building your program: Understand reimbursement, safety, and multidisciplinary integration so you can strengthen or expand your Y90 practice in any setting.

A highlight of this course is the simulation lab. You will work directly with case-based scenarios to plan and verify treatments, calculate particle density, and test dose prescriptions. The goal is not theory but applied skills you can take home and use with your next patient.

If you are:

• An interventional radiologist aiming to sharpen Y90 techniques
• A nuclear medicine physician looking to bridge into advanced dosimetry
• A radiation oncologist expanding your liver-directed therapy toolkit

This course is for you. Whether you are in academic medicine or private practice, you will leave better equipped to deliver precise, patient-centered care.

• Pre-Conference Date: Thursday, October 16, 2025
• Main Conference Dates: October 17–19, 2025
• Location: Loews Miami Beach Hotel, Miami Beach, Florida
• Event Website
• Pre-Conference Educational Program
• CIO Educational Program
• Registration

I am proud to serve as a course director at CIO because this meeting consistently sets the standard for interventional oncology education. On October 16, I look forward to working with you side by side as we sharpen our approach to Y90 therapy, improve outcomes, and advance cancer care together.

Ripal Gandhi, MD is an interventional radiologist at Miami Cardiac and Vascular Institute, Miami Cancer Institute, Baptist Health South Florida. He is the Course Director of the Symposium on Clinical Interventional Oncology (CIO).

This article originally appeared here on the HMP Global blog. It has been republished with permission.